Thomas Ebeling was born in 1959. After earning a degree in psychology from Hamburg University, he began his career with Reemtsma in 1987. In 1991, he moved to Pepsi-Cola Germany, where he served as a marketing manager. Starting in 1994, he was National Sales and Franchise Director for the retail and restaurant sales of Pepsi-Cola, and in 1996, he was appointed General Manager of Pepsi-Cola Germany. In 1997, he switched to Novartis as General Manager of Novartis Nutrition for Germany and Austria. In 1998, Thomas Ebeling assumed worldwide leadership of the Novartis Nutrition Division. In 1998, he was appointed to the Novartis Executive Committee. From 2000 to October 2007, he served as CEO of the global Novartis pharmaceuticals business. Under his leadership, the company's revenues more than doubled from US$11 billion to US$22.6 billion. In October 2007, he was appointed CEO of the Novartis Consumer Health Division. Since March 2009, he is CEO of ProSiebenSat.1 Media SE. Thomas Ebeling was appointed to the Supervisory Board of Bayer AG in 2012. Since April 2017 he has been member of the Supervisory Board of GfK SE.
Pascal Bérard is a joint PhD student at the Computer Graphics Lab at ETH Zurich and at Disney Research Zurich. He is researching new methods to capture, model, and animate virtual humans for applications in the visual effects industry. Pascal’s primary focus is on the human eye and he designed new systems for the acquisition and creation of high-fidelity models of human eyes. Pascal contributed to movies like Rogue One: A Star Wars Story and Doctor Strange and he recently made it onto the Forbes 30 under 30 Europe list.